High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas.

• Authors: J D Bitran, S F Williams, J Moormeier, R Mick
• Journal: Seminars in oncology (Semin Oncol) Vol. 17 Issue 1 Suppl 3 Pg. 39-42 (Feb 1990) ISSN: 0093-7754 [Print] United States
• PMID: 1968290 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Thiotepa

Topics

• Adult
• Combined Modality Therapy
• Female
• Hematopoietic Stem Cell Transplantation
• Hodgkin Disease (mortality, therapy)
• Humans
• Lymphoma (mortality, therapy)
• Male
• Middle Aged
• Recurrence
• Remission Induction
• Survival Rate
• Thiotepa (adverse effects, therapeutic use)